NLRP3-IN-32
NLRP3-IN-32 (compound 7a), a 3, 4-dihydronaphthalene-1 (2H) -one derivative, is a potential NLRP3 inflammatory vesicles inhibitor. NLRP3-IN-32 can block the assembly and activation of NLRP3 inflammasome by down-regulating the expression of NLPR3 and apoptosis-associated speck-like protein containing a CARD (ASC), and inhibiting the production of reactive oxygen species (ROS) and other inflammatory mediators. NLRP3-IN-32 inhibits the phosphorylation of IκBα and NF-κB/p65 and the nuclear translocation of p65, thereby inhibiting NF-κB signaling[1].
Product Specifications
UNSPSC
12352005
Target
IKK; NF-κB; NOD-like Receptor (NLR) ; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/nlrp3-in-32.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(CC/2)C=CC(Br)=C1)C2=C\C3=NC=C(N4CCN(C)CC4)C=C3
Molecular Formula
C21H22BrN3O
Molecular Weight
412.32
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NLRP3; RelA/p65
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog